Explore tweets tagged as #OptometryTimes
Sparked by the recent CRL received by Sydnexis from the US FDA regarding its 0.01% atropine formulation (SYD-101), the AAOMC recently released a statement urging for the US to reexamine the classification of progressive myopia. Read more: https://t.co/Gkv3c2M3GX
0
0
0
Grateful for the eye-care professionals who bring clarity, comfort, and better vision to patients every day. Wishing you a spec-tacular 👓 and restorative Thanksgiving! 🦃 #thanksgiving #eyecare
0
0
2
Celebrated world Optometry Day at #SuperuorUniversityLahore A seminar and Awareness walk on Optometrist role in the prevention and control of available causes of blindness in Pakistan was conducted. @adeel_azhar
@WorldCouncilOpt
@OptometryTimes
@revoptom
@nhsrcofficial
0
1
6
Kaleb Abbott, OD, MS, FAAO, FOWNS; and Andrew Pucker, OD, PhD, FAAO, FSLS, FBCLA, are advocating for refreshed terminology when it comes to artificial drops. Read more: https://t.co/vclkzDTDQz
0
0
1
"People can’t see without them, and yet they are often overlooked in routine ophthalmic examinations," writes Jim Williamson, OD, FAAO, FORS. Read more: https://t.co/0d6v1Sv5Pk
0
1
0
Signals that originate from the vestibular system of the inner ear stabilize the retinal images as the body moves and the head tilts. Read more: https://t.co/rJ7UKaXWa9
0
0
1
Big thanks to @OptometryTimes for celebrating our Refractive Error Among Children (REACH) program in India. 📷🇮🇳 Since its inception 5 years ago, REACH has provided: -172,000+ prescriptions -116,000+ pairs of glasses -2,000+ surgery referrals All for children! 👧👦
1
2
15
We have begun rolling out our Crafting Your Own Eyewear series with Dr Diana Canto-Sims! Check out our landing page to watch video interviews with 4 companies that specialize in helping optometric practices launch their own brands: https://t.co/VWDCGlIf7V
0
1
0
The FDA has granted fast track designation to Epion Therapeutics' EpiSmart epithelium-on cross-linking system. The company stated that the expedited program will accelerate development of its novel drug-device combination. Read more: https://t.co/hYs7TT283g
0
0
3
CLI Visionary, Shelby Brogdon, OD, shared our recent research with @OptometryTimes during @aaopt #Academy2025. The study examined how Gen Z, Gen X, and Millennials approach contact lens usage. Watch https://t.co/N1UqgkLdXD then visit https://t.co/94NcQlbdD6 for more data.
0
0
1
A recent national survey commissioned by TheraTears has found that as many as 3 in 4 American patients experience dry eye symptoms weekly, and these symptoms are more severe than a minor irritation. Read more: https://t.co/mRRvqpDcbg
0
0
1
The recent American Academy of Optometry (AAO) 2025 annual meeting in Boston offered attendees some insights into clinicians’ thoughts about the conference. Optometry Times presented clinicians with a question about their practices. Read more: https://t.co/urtO28OnEQ
0
1
1
Topline results that were recently released from Sydnexis’s phase 3 STAR trial of SYD-101 (atropine 0.01%) for slowing the progression of myopia in children demonstrated that the trial met its primary efficacy and key secondary end points. Read more: https://t.co/v6t0dRGWlb
0
0
2
"I have been enamored of fairy tales and nursery rhymes since childhood. Whether it’s an Aesop fable or a spontaneous rhyme, I seem to have one for every situation," writes Katherine M. Mastrota, MS, OD, FAAO, Dipl ABO. Read more: https://t.co/Zsvy2DerBX
0
0
1
0
0
0
0
2
3
Pediatric myopia and keratoconus: Cross-linking and ortho-k in children - Part 2 In part 2 of the pediatric myopia and keratoconus series, Drs Chan and Swartz dive into ortho-k and crosslinking in children. https://t.co/vN5oxvZYP9 via @OptometryTimes
0
0
2
Study: Children with vision impairment have reduced quality of life https://t.co/jIqqeERDWE via @optometrytimes
0
0
1
Congratulations on another successful event @mclosaofficial @normanmackay3 @OptometryTimes @_BCLA @OphthoMag @Ophthalmic_TU #eyes
0
3
4